Safety and Immunogenicity of Hepatitis A Vaccine in Infants: A Candidate for Inclusion in the Childhood Vaccination Programme

Vaccine. 1999 Feb 12;17(6):585-8. doi: 10.1016/s0264-410x(98)00237-0.

Abstract

Forty-eight infants received a single dose (720 ELISA units = 0.5 ml) of inactivated hepatitis A vaccine at the fifth month of age with booster at the 11th month of age, together with the second and third doses of the vaccines compulsory under Italian law (diphtheria, tetanus, oral polio and hepatitis B). Overall, the seroconversion rate was 100%. The anti-HAV geometric mean titre (GMT) reached 3,021 mIU/ml in infants born to anti-HAV-negative mothers, but only 399 mIU/ml in infants born to anti-HAV-positive mothers. Hepatitis A vaccine was immunogenic, safe and well tolerated without significant side-effects. There seems to be no reason for not including it in childhood vaccination programmes particularly in low endemic HAV areas.

MeSH terms

  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Hepatitis A Antibodies
  • Hepatitis A Vaccines
  • Hepatitis Antibodies / blood
  • Humans
  • Immunoglobulin G / blood
  • Infant
  • Male
  • Vaccination*
  • Viral Hepatitis Vaccines / adverse effects
  • Viral Hepatitis Vaccines / immunology*

Substances

  • Hepatitis A Antibodies
  • Hepatitis A Vaccines
  • Hepatitis Antibodies
  • Immunoglobulin G
  • Viral Hepatitis Vaccines